Erie County Medical Center (ECMC) Corporation Hepatology Medical Director Anthony Martinez was recently appointed co-chairman of the Chronic Liver Disease Foundation HCV (Hepatitis C Virus) committee.
The Chronic Liver Disease Foundation, Inc., based in Clark, New Jersey, is comprised of leading hepatology specialists committed to raising awareness of the effects of chronic liver disease (CLD) and sharing latest insights and analyses with the global healthcare community and patients.
Physician Martinez is medical director of the Center for Hepatology Care at ECMC where he cares for patients with liver disease and addiction disorders, including opiate dependency, viral hepatitis, alcoholic and fatty liver disease.
His clinic “La Bodega” has been recognized both nationally and internationally as a novel co-localized model for the management of viral hepatitis and addiction disorders. His team’s work has been presented at the annual liver meeting of the American Association for the Study of Liver; the annual conference of the International Network On Viral Hepatitis in Substance Users; and at the International Liver Congress.
Martinez is also associate professor of medicine at University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, where he was awarded the clinical faculty for scholarship and nominated for the Siegel Award for Teaching Excellence.
Martinez has lectured around the world on hepatitis C management among people with substance use disorders. His research involves improving hepatitis C treatment in populations disproportionately affected by HCV, particularly people who inject drugs. He has been a primary and co-investigator on numerous clinical trials related to new therapeutic agents for hepatitis C and fatty liver disease, and he is board-certified by the American Academy of HIV Medicine. A fierce advocate, he works to eliminate hepatitis C treatment restrictions throughout the United States and in Europe.
Martinez is a fellow of the American Association for the Study of Liver Disease where he serves on the HCV special interest group steering committee; the European Association for the Study of The Liver; and the American Society of Addiction Medicine.